Pathogenic shifts in endogenous microbiota impede tissue regeneration via distinct activation of TAK1/MKK/p38

  1. Christopher P Arnold
  2. M Shane Merryman
  3. Aleishia Harris-Arnold
  4. Sean A McKinney
  5. Chris W Seidel
  6. Sydney Loethen
  7. Kylie N Proctor
  8. Longhua Guo
  9. Alejandro Sánchez Alvarado  Is a corresponding author
  1. Stowers Institute for Medical Research, United States
  2. University of Missouri, United States
  3. Pittsburg State University, United States

Abstract

The interrelationship between endogenous microbiota, the immune system, and tissue regeneration is an area of intense research due to its potential therapeutic applications. We investigated this relationship in Schmidtea mediterranea, a model organism capable of regenerating any and all of its adult tissues. Microbiome characterization revealed a high Bacteroidetes to Proteobacteria ratio in healthy animals. Perturbations eliciting an expansion of Proteobacteria coincided with ectopic lesions and tissue degeneration. Culture of these bacteria yielded a strain of Pseudomonas capable of inducing progressive tissue degeneration. RNAi screening uncovered a TAK1 innate immune signaling module underlying compromised tissue homeostasis and regeneration during infection. TAK1/MKK/p38 signaling mediated opposing regulation of apoptosis during infection versus normal tissue regeneration. Given the complex role of inflammation in either hindering or supporting reparative wound healing and regeneration, this invertebrate model provides a basis for dissecting the duality of evolutionarily conserved inflammatory signaling in complex, multi-organ adult tissue regeneration.

Article and author information

Author details

  1. Christopher P Arnold

    Stowers Institute for Medical Research, Kansas City, United States
    Competing interests
    No competing interests declared.
  2. M Shane Merryman

    Stowers Institute for Medical Research, Kansas City, United States
    Competing interests
    No competing interests declared.
  3. Aleishia Harris-Arnold

    Stowers Institute for Medical Research, Kansas City, United States
    Competing interests
    No competing interests declared.
  4. Sean A McKinney

    Stowers Institute for Medical Research, Kansas City, United States
    Competing interests
    No competing interests declared.
  5. Chris W Seidel

    Stowers Institute for Medical Research, Kansas City, United States
    Competing interests
    No competing interests declared.
  6. Sydney Loethen

    University of Missouri, Kansas City, United States
    Competing interests
    No competing interests declared.
  7. Kylie N Proctor

    Pittsburg State University, Pittsburg, United States
    Competing interests
    No competing interests declared.
  8. Longhua Guo

    Stowers Institute for Medical Research, Kansas City, United States
    Competing interests
    No competing interests declared.
  9. Alejandro Sánchez Alvarado

    Stowers Institute for Medical Research, Kansas City, United States
    For correspondence
    asa@stowers.org
    Competing interests
    Alejandro Sánchez Alvarado, Reviewing editor, eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1966-6959

Funding

Howard Hughes Medical Institute

  • Alejandro Sánchez Alvarado

National Institute of General Medical Sciences (R37GM057260)

  • Alejandro Sánchez Alvarado

Stowers Institute for Medical Research

  • Alejandro Sánchez Alvarado

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Richard Losick, Harvard University, United States

Version history

  1. Received: April 8, 2016
  2. Accepted: July 19, 2016
  3. Accepted Manuscript published: July 21, 2016 (version 1)
  4. Accepted Manuscript updated: July 28, 2016 (version 2)
  5. Version of Record published: August 22, 2016 (version 3)

Copyright

© 2016, Arnold et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 5,365
    views
  • 975
    downloads
  • 80
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Christopher P Arnold
  2. M Shane Merryman
  3. Aleishia Harris-Arnold
  4. Sean A McKinney
  5. Chris W Seidel
  6. Sydney Loethen
  7. Kylie N Proctor
  8. Longhua Guo
  9. Alejandro Sánchez Alvarado
(2016)
Pathogenic shifts in endogenous microbiota impede tissue regeneration via distinct activation of TAK1/MKK/p38
eLife 5:e16793.
https://doi.org/10.7554/eLife.16793

Share this article

https://doi.org/10.7554/eLife.16793

Further reading

    1. Developmental Biology
    2. Stem Cells and Regenerative Medicine
    Mayank Verma, Yoko Asakura ... Atsushi Asakura
    Research Article Updated

    Endothelial and skeletal muscle lineages arise from common embryonic progenitors. Despite their shared developmental origin, adult endothelial cells (ECs) and muscle stem cells (MuSCs; satellite cells) have been thought to possess distinct gene signatures and signaling pathways. Here, we shift this paradigm by uncovering how adult MuSC behavior is affected by the expression of a subset of EC transcripts. We used several computational analyses including single-cell RNA-seq (scRNA-seq) to show that MuSCs express low levels of canonical EC markers in mice. We demonstrate that MuSC survival is regulated by one such prototypic endothelial signaling pathway (VEGFA-FLT1). Using pharmacological and genetic gain- and loss-of-function studies, we identify the FLT1-AKT1 axis as the key effector underlying VEGFA-mediated regulation of MuSC survival. All together, our data support that the VEGFA-FLT1-AKT1 pathway promotes MuSC survival during muscle regeneration, and highlights how the minor expression of select transcripts is sufficient for affecting cell behavior.

    1. Biochemistry and Chemical Biology
    2. Stem Cells and Regenerative Medicine
    Parthasarathy Sampathkumar, Heekyung Jung ... Yang Li
    Research Article

    Molecules that facilitate targeted protein degradation (TPD) offer great promise as novel therapeutics. The human hepatic lectin asialoglycoprotein receptor (ASGR) is selectively expressed on hepatocytes. We have previously engineered an anti-ASGR1 antibody-mutant RSPO2 (RSPO2RA) fusion protein (called SWEETS) to drive tissue-specific degradation of ZNRF3/RNF43 E3 ubiquitin ligases, which achieved hepatocyte-specific enhanced Wnt signaling, proliferation, and restored liver function in mouse models, and an antibody–RSPO2RA fusion molecule is currently in human clinical trials. In the current study, we identified two new ASGR1- and ASGR1/2-specific antibodies, 8M24 and 8G8. High-resolution crystal structures of ASGR1:8M24 and ASGR2:8G8 complexes revealed that these antibodies bind to distinct epitopes on opposing sides of ASGR, away from the substrate-binding site. Both antibodies enhanced Wnt activity when assembled as SWEETS molecules with RSPO2RA through specific effects sequestering E3 ligases. In addition, 8M24-RSPO2RA and 8G8-RSPO2RA efficiently downregulate ASGR1 through TPD mechanisms. These results demonstrate the possibility of combining different therapeutic effects and degradation mechanisms in a single molecule.